What is XG Sciences?
Founded in 2006 and headquartered in Lansing, Michigan, XG Sciences operates at the intersection of nanotechnology and industrial manufacturing. The company specializes in the production of graphene nanoplatelets, a versatile material essential for enhancing the performance of concrete, 3D printing resins, and silicon-graphene lithium-ion battery anodes. By focusing on high-performance bulk materials, XG Sciences addresses the growing demand for advanced composites that offer superior flexural modulus and thermal conductivity. Their market position is defined by a commitment to bridging the gap between laboratory-scale innovation and large-scale commercial deployment, effectively serving sectors ranging from energy storage to infrastructure development.
How much funding has XG Sciences raised?
XG Sciences has raised a total of $886K across 2 funding rounds:
Debt
$350K
Debt
$536K
Debt (2020): $350K with participation from PPP
Debt (2021): $536K led by PPP
Key Investors in XG Sciences
PPP
Public-Private Partnership
What's next for XG Sciences?
With the recent capital injection, XG Sciences is well-positioned to accelerate its research and development initiatives, particularly in the high-growth battery technology sector. The strategic focus will likely shift toward optimizing manufacturing efficiencies to meet the rigorous demands of enterprise-level clients. By leveraging this financing, the company aims to solidify its competitive advantage in the graphene market, potentially expanding its patent portfolio and deepening its integration into the supply chains of major automotive and construction firms. The path forward involves scaling operations to ensure that their advanced material solutions remain both cost-effective and scalable for mass-market adoption.
See full XG Sciences company page
